« Back to Record
Piette, C., Suciu, S., Clappier, E., Bertrand, Y., Drunat, S., Girard, S., Yakouben, K., Plat, G., Dastugue, N., Mazingue, F., Grardel, N., van Roy, N., Uyttebroeck, A., Costa, V., Minckes, O., Sirvent, N., Simon, P., Lutz, P., Ferster, A., Pluchart, C., Poirée, M., Freycon, C., Dresse, M.-F., Millot, F., Chantrain, C., van der Werff Ten Bosch, J., Norga, K., Gilotay, C., Rohrlich, P.-S., Benoît, Y., & Cavé, H. (2018). Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukaemia: results of the EORTC CLG 58881 and 58951 trials. Leukemia, 32(1), 244-248. doi:10.1038/leu.2017.289
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/264794



